Add like
Add dislike
Add to saved papers

Remote ischemic per-conditioning protects against renal ischemia-reperfusion injury via suppressing gene expression of TLR4 and TNF-α in rat model.

BACKGROUND: The pathogenesis of renal ischemic reperfusion injury (IRI) involves both inflammatory processes and oxidative stress in the kidney. This study determined whether remote ischemic per-conditioning (RIPerC) is mediated by toll-like receptor 4 (TLR4) signaling pathway in rats.

MATERIALS AND METHODS: Renal I/R injury was induced by occluding renal arteries for 45 min followed by 24 h reperfusion. RIPerC included four cycles of 2 minutes ischemia of left femoral artery followed by 3 minutes reperfusion performed at the start of renal ischemia. Rats were grouped into sham, I/R, and RIPerC. At the ending of reperfusion period, urine, blood and tissue samples were gathered.

RESULTS: I/R created kidney dysfunction, as ascertained by significant decrease in creatinine clearance, and significant increase in sodium fractional excretion. This was occurred with a decrease in the activities of gluthatione peroxidase, catalase and superoxidae dismutase with an increment in malondialdehyde levels, mRNA expression levels of Toll-like receptor 4 (TLR4) and tumor necrosis factor-alpha (TNF-α) and histological damages in renal tissues. RIPerC treatment diminished all these changes.

CONCLUSION: This study demonstrated that RIPerC has protective effects on the kidney after renal I/R, which might be related with inhibition of TLR4 signaling pathway and augmentation of anti-oxidant systems.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

Managing Alcohol Withdrawal Syndrome.Annals of Emergency Medicine 2024 March 26

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app